Johnson & Johnson Pauses Vaccine Study After Unexplained Illness
Johnson & Johnson is investigating after one of the participants in its study on a potential coronavirus vaccine became ill.
A second COVID-19 vaccine in the late stages of its study has been put on pause.
Johnson & Johnson is investigating after one of the study's participants came down with an unexplained illness. The company is looking into whether the illness is connected to the vaccine.
Johnson & Johnson said pauses like this are expected as part of the process, but it did not release any details about the illness.
Final testing for a vaccine created by AstraZeneca is still on hold in the U.S. as officials investigate an illness connected to that study as well.
President Biden to end emergency declarations for COVID
Those free at home COVID tests are expected to be a thing of the past after the emergency declaration ends.By Tsvangirayi Mukwazhi / AP
President Biden to end COVID-19 emergencies May 11
This comes as lawmakers have already ended elements of the emergencies that kept millions of Americans insured during the pandemic.By Susan Walsh / AP
WHO says COVID remains an emergency but is in transition
The World Health Organization said there is still uncertainty in COVID-19's future, but the virus is at a "transition point."By Shutterstock
Democrats introduce bills intended to bolster Black history education
Advocates for the legislation said it would invest $10 million over five years in the National Museum of African American History and Culture.By Mariam Zuhaib / AP
Planning a home project? Here's how supplies, prices will be in 2023
After two years of shortages and delays, things starting to improve.By Rogelio V. Solis / AP
Grammys could make history with Beyoncé, Bad Bunny wins
A win by Bad Bunny would mark the first time a Spanish-language album has taken home the top honor.By AP